US wait times for cancer surgeries are getting longer and longer

**Commentary by Dr. Iris Vale** The scalpel of progress has a blunt edge. A new study confirms what too many oncologists whisper in hallway consults: wait times for cancer surgery in the U.S. have stretched to a decade-long worst. This isn’t an administrative footnote; it’s a biological clock ticking against every patient whose tumor grows while they wait for a date on the OR schedule. When we ration time, we ration life itself. This trend signals a systemic fracture—not just in staffing or beds, but in the triage of a society that prioritizes elective volume over urgent complexity. It connects to the broader crisis of care access, where zip codes and insurance grids dictate whether a patient waits weeks or months. The pandemic may have loosened the seams, but the underlying fabric was already frayed. If we accept this as the new normal, we are complicit in a quiet tragedy. Every delayed surgery is a measured loss of survival probability. We need a national standard for oncologic urgency, not just a default of “whenever we can.” Otherwise, the longest wait isn’t in the waiting room—it’s between diagnosis and hope. --- {"key_insight":"Delayed cancer surgery isn't a scheduling problem; it's a survival equation being quietly rewritten against the patient.", "confidence":0.92}